Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG [Phase 1]
A Phase I trial evaluating imatinib (Gleevec) in combination with everolimus (RAD001) and hydroxyurea in patients with recurrent glioblastom…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas [Phase 1]
A Phase I trial evaluated adding a Farnesyl Transferase Inhibitor to temozolomide in patients with Grade 3-4 malignant gliomas, and the stud…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas [Phase 1]
Phase I dose-escalation study of Vandetanib in combination with Etoposide for malignant gliomas (glioblastoma and gliosarcoma) has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: RO4929097 in Treating Patients With Recurrent Invasive Gliomas [Phase 1]
Phase 1 trial update for RO4929097 in recurrent invasive gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Phase 2]
Phase II trial evaluating bevacizumab with temozolomide or etoposide in glioblastoma or gliosarcoma patients who progressed after bevacizuma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Phase 2]
A phase 2 trial evaluating Gliadel implants followed by bevacizumab (Avastin) and irinotecan for glioblastoma multiforme was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma [Phase 3]
A Phase 3 trial evaluating radiotherapy with Carmustine, with or without O6-benzylguanine, in newly diagnosed glioblastoma multiforme or gli…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oxaliplatin for newly diagnosed glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib in Treating Patients With Recurrent Glioma [Phase 1]
Phase 1 trial evaluating bortezomib in adults with recurrent glioma; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant plus adjuvant fenretinide versus adjuvant fenretinide alone in patients undergoing surgery for…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Phase 2]
Phase 2 trial evaluating Avastin with radiation and temozolomide, followed by Avastin, temozolomide and irinotecan in glioblastoma and glios…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating Avastin with radiation and temozolomide, followed by Avastin/temozolomide/topotecan in glioblastoma patien…
-
CLINICAL_TRIALS research · 2013-01-16Clinical Trial Update: Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma [NA]
A terminated clinical trial evaluated the use of EF5 to measure oxygen levels in tumor cells of patients with newly diagnosed supratentorial…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in combination with hydroxyurea for patients with recurrent or progressive gliobl…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma [Phase 1]
Phase 1 trial evaluating vandetanib (Zactima) in combination with imatinib mesylate and hydroxyurea for recurrent malignant glioma (glioblas…
-
CLINICAL_TRIALS withdrawal · 2012-11-21Clinical Trial Update: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma [Phase 1]
A Phase I trial of dasatinib in combination with protracted temozolomide for recurrent malignant glioma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors [Phase 2]
Phase 2 trial evaluating Tarceva, Temodar, and radiation therapy in newly diagnosed brain tumors (glioblastoma multiforme and gliosarcoma) c…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Phase 2]
This Phase 2 trial of Avastin in combination with temozolomide for unresectable or multifocal glioblastoma and gliosarcoma has completed and…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors [Phase 2]
A Phase 2 trial evaluated tandutinib in combination with bevacizumab for recurrent brain tumors, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluated gefitinib in combination with radiation therapy for newly diagnosed gliomas; the study completed and r…
-
CLINICAL_TRIALS research · 2010-07-16Clinical Trial Update: Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating hyperbaric oxygen in combination with radiotherapy and temozolomide for adults with newly diagnosed gliobl…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A completed Phase 2 trial evaluating lenalidomide in combination with external beam radiation therapy for newly diagnosed glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma [Phase 2]
This document provides an update on a Phase 2 clinical trial of 131-I-TM-601 in adults with recurrent high-grade glioma, sponsored by TransM…
-
CLINICAL_TRIALS trial_result · 2009-01-22Clinical Trial Update: Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma [Phase 2]
A Phase II study of temozolomide for newly diagnosed glioblastoma and gliosarcoma was terminated.